NCI boosts University of Hawaiʻi Cancer Center support to $8.4M

June 16, 2019

The National Cancer Institute (NCI) has increased support of the University of Hawaiʻi Cancer Center under the Cancer Center Support Grant from $5.7 million to $8.4 million, and has extended the term of the current NCI designation by an additional year to July 2022. The funding supports core research infrastructure at the UH Cancer Center that is essential for researchers to conduct studies targeted at reducing the burden of cancer for the people of Hawaiʻi and the Pacific.

“We are extremely pleased that the National Cancer Institute has recognized the incredible contributions that our investigators have made toward understanding the etiologies of cancer and toward the development of novel cancer prevention and treatment approaches,” said UH Cancer Center Director Randall Holcombe.

In addition to basic laboratory and population-based research, the center conducts cancer prevention and control research and provides access to clinical trials for most of the patients in the state in collaboration with clinical partners in the Hawaiʻi Cancer Consortium. Among the many highlights noted by NCI at the time of the last review in 2018, the community outreach and engagement component of the UH Cancer Center was rated as “exceptional,” the highest rating possible. This is a reflection of the commitment of the UH Cancer Center to serving the people of Hawaiʻi.

Read more about NCI's support for the UH Cancer Center